Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Dual-Level Pattern Tree for Visual Field Characterization in Glaucoma Improves Predicting Progression and Polygenic Risk Score
Author Affiliations & Notes
  • Luo Song
    Harvard Ophthalmology AI Lab, Schepens Eye Research Institute of Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, United States
    UQ - Ochsner Clinical School, Ochsner Health, New Orleans, Louisiana, United States
  • Lucy Q Shen
    Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, United States
  • Louis R Pasquale
    Eye and Vision Research Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States
  • Michael V Boland
    Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, United States
  • Sarah Wellik
    Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami, Florida, United States
  • Carlos Gustavo De Moraes
    Edward S. Harkness Eye Institute, Columbia University Irving Medical Center, New York, New York, United States
  • Jonathan S. Myers
    Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania, United States
  • Tobias Elze
    Harvard Ophthalmology AI Lab, Schepens Eye Research Institute of Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, United States
  • Nazlee Zebardast
    Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, United States
  • David S Friedman
    Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, United States
  • Jae H Kang
    Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States
  • Mengyu Wang
    Harvard Ophthalmology AI Lab, Schepens Eye Research Institute of Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Luo Song None; Lucy Shen None; Louis Pasquale Twenty-Twenty and Character Bio, Code C (Consultant/Contractor); Michael Boland Carl Zeiss Meditec, Code C (Consultant/Contractor), Topcon Healthcare, Code C (Consultant/Contractor), Allergan, Code C (Consultant/Contractor), Janssen, Code C (Consultant/Contractor); Sarah Wellik None; Carlos Moraes None; Jonathan Myers None; Tobias Elze Genentech Inc., Code F (Financial Support); Nazlee Zebardast None; David Friedman Abbvie, Code C (Consultant/Contractor), Life Biosciences, Code C (Consultant/Contractor), Thea Pharmaceuticals, Code C (Consultant/Contractor), Genentech, Code F (Financial Support), Perivision, Code F (Financial Support); Jae Kang None; Mengyu Wang Genentech Inc., Code F (Financial Support)
  • Footnotes
    Support  NIH R00 EY028631, NIH R21 EY035298, Research to Prevent Blindness International Research Collaborators Award, Alcon Young Investigator Grant, Grimshaw-Gudewicz Grant, NIH R01 EY030575, NIH P30 EY003790, NIH R01 EY015473, and NIH R01 EY032559.
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 6477. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Luo Song, Lucy Q Shen, Louis R Pasquale, Michael V Boland, Sarah Wellik, Carlos Gustavo De Moraes, Jonathan S. Myers, Tobias Elze, Nazlee Zebardast, David S Friedman, Jae H Kang, Mengyu Wang; Dual-Level Pattern Tree for Visual Field Characterization in Glaucoma Improves Predicting Progression and Polygenic Risk Score. Invest. Ophthalmol. Vis. Sci. 2024;65(7):6477.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To develop a dual-level pattern tree that more adequately represents visual field loss subtypes in glaucoma, which may better forecast progression and correlate with genetic variations.

Methods : Three datasets were used in this study: (1) the Glaucoma Research Network (GRN) dataset excluding the Massachusetts Eye and Ear (MEE)partition for the dual-level pattern tree model training, (2) the MEE longitudinal dataset for progression forecasting, and (3) the Nurses' Health Studies and Health Professionals Follow-up Study datasets for polygenic risk score (PRS) analyses. We first applied archetypal analysisto cluster 24-2 VFs into parent patterns and their own child patterns. The Cox regression modelforecasted the VF progression with four widely used progression definitions: slope of MD, MD-Fast, VFI, and TD pointwise. Pearson's correlations analyzed relationships between VF patterns and PRS.

Results : 182,548 VFs from 103,856 glaucoma patients in GRN were used to train the dual-level archetypal model. It contains 17 parent patterns with 118,059 VFs as the largest group (Parent 1) and 1,161 VFs as the smallest group (Parent 11). The second level contains a total of 169 child patterns (child pattern numbers under each parent pattern: 9.9 ± 1.6). Figure 1 shows all parent patterns and their child patterns. 119,856 VFs from 8,442 MEE patients were used for Cox progression prediction. Figure 2(A) shows parent-child patterns are consistently if modestly superior to parent patterns only for progression forecasting measured by the average area under the curve (average AUC): MD (0.62 vs 0.60), MD-Fast (0.79 vs 0.75), VFI (0.67 vs 0.64) and TD Pointwise (0.71 vs 0.69) with all p < 0.001. PRS relationship analysis with 732 VFs shows the child patterns are generally more strongly associated with PRS than parent patterns, as shown in Figure 2(B), in which the P3-C7 pattern (Child Pattern 7 under Parent Pattern 3) (R = 0.35; p = 0.003) shows a higher correlation than P3 (R = 0.15, p = 0.213) and the P7-C3 pattern (R = 0.57; p = 0.03) shows a higher correlation than P7 (R = 0.33, p = 0.24).

Conclusions : The dual-level pattern characterization for VFs predicts VF progression better and shows a stronger association with PRS which may facilitate a better understanding of glaucoma subtypes related to different progression trajectories and genomic variants..

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

 

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×